Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epitopes | 5 | 2021 | 2526 | 1.170 |
Why?
|
Antigens, Neoplasm | 12 | 2022 | 1997 | 1.100 |
Why?
|
Peptides | 19 | 2022 | 4348 | 1.030 |
Why?
|
Histocompatibility Antigens Class I | 6 | 2022 | 1362 | 0.910 |
Why?
|
Cancer Vaccines | 8 | 2024 | 1041 | 0.870 |
Why?
|
Polyomavirus Infections | 2 | 2023 | 192 | 0.870 |
Why?
|
Influenza A virus | 3 | 2015 | 455 | 0.760 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2023 | 329 | 0.740 |
Why?
|
Epitopes, T-Lymphocyte | 12 | 2021 | 827 | 0.660 |
Why?
|
CD8-Positive T-Lymphocytes | 11 | 2024 | 4648 | 0.650 |
Why?
|
Databases, Protein | 2 | 2019 | 390 | 0.600 |
Why?
|
Pemphigus | 5 | 2011 | 107 | 0.530 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 8 | 2020 | 820 | 0.510 |
Why?
|
T-Lymphocytes | 18 | 2021 | 10254 | 0.500 |
Why?
|
Proteome | 3 | 2021 | 1890 | 0.430 |
Why?
|
Receptors, Antigen, T-Cell | 8 | 2021 | 2568 | 0.360 |
Why?
|
Lung | 4 | 2023 | 10076 | 0.330 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 7 | 2006 | 117 | 0.330 |
Why?
|
Skin Neoplasms | 4 | 2023 | 5859 | 0.320 |
Why?
|
HLA Antigens | 9 | 2022 | 1334 | 0.310 |
Why?
|
T-Cell Antigen Receptor Specificity | 2 | 2018 | 89 | 0.300 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2010 | 667 | 0.290 |
Why?
|
Immunotherapy | 7 | 2021 | 4745 | 0.290 |
Why?
|
Receptors, IgG | 2 | 2008 | 563 | 0.280 |
Why?
|
Decidua | 1 | 2007 | 82 | 0.270 |
Why?
|
Single-Cell Analysis | 4 | 2023 | 2538 | 0.270 |
Why?
|
Melanoma | 7 | 2022 | 5702 | 0.270 |
Why?
|
Killer Cells, Natural | 4 | 2023 | 2209 | 0.260 |
Why?
|
Myelin Proteolipid Protein | 3 | 2018 | 107 | 0.250 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2024 | 1801 | 0.250 |
Why?
|
Nitrates | 1 | 2006 | 259 | 0.250 |
Why?
|
Cytokines | 7 | 2023 | 7446 | 0.240 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 4 | 2020 | 1642 | 0.220 |
Why?
|
Chemokines | 2 | 2024 | 963 | 0.220 |
Why?
|
Multiple Sclerosis | 4 | 2020 | 3229 | 0.220 |
Why?
|
Glioblastoma | 1 | 2018 | 3461 | 0.220 |
Why?
|
Tryptophan Oxygenase | 5 | 2003 | 19 | 0.220 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2018 | 303 | 0.210 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 637 | 0.210 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2024 | 705 | 0.200 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2017 | 812 | 0.200 |
Why?
|
Lymphocyte Activation | 9 | 2021 | 5499 | 0.200 |
Why?
|
Dexamethasone | 2 | 2020 | 1963 | 0.200 |
Why?
|
Antigens, Viral, Tumor | 1 | 2022 | 153 | 0.190 |
Why?
|
Dendritic Cells | 6 | 2024 | 2745 | 0.190 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2017 | 453 | 0.180 |
Why?
|
Lymphocyte Transfusion | 1 | 2021 | 232 | 0.180 |
Why?
|
Genes, MHC Class II | 2 | 2012 | 433 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 2 | 2023 | 1854 | 0.180 |
Why?
|
Viruses | 2 | 2022 | 371 | 0.170 |
Why?
|
Antigen Presentation | 5 | 2021 | 1250 | 0.170 |
Why?
|
Cell Line | 12 | 2023 | 15567 | 0.170 |
Why?
|
Immunologic Memory | 4 | 2021 | 1377 | 0.170 |
Why?
|
Tumor Virus Infections | 1 | 2023 | 437 | 0.170 |
Why?
|
Neoplasms | 11 | 2023 | 22350 | 0.170 |
Why?
|
Amino Acid Motifs | 2 | 2019 | 928 | 0.160 |
Why?
|
Immune Tolerance | 4 | 2018 | 2322 | 0.160 |
Why?
|
Pemphigoid, Bullous | 2 | 2010 | 110 | 0.160 |
Why?
|
Neuromyelitis Optica | 1 | 2022 | 266 | 0.150 |
Why?
|
Chromatography, Liquid | 3 | 2021 | 996 | 0.150 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 207 | 0.150 |
Why?
|
Open Reading Frames | 1 | 2021 | 818 | 0.150 |
Why?
|
Immunity | 1 | 2023 | 1002 | 0.140 |
Why?
|
Humans | 66 | 2024 | 767040 | 0.140 |
Why?
|
Substrate Specificity | 1 | 2021 | 1750 | 0.140 |
Why?
|
Mass Spectrometry | 5 | 2022 | 2201 | 0.140 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 342 | 0.140 |
Why?
|
Peptide Hydrolases | 1 | 2019 | 610 | 0.140 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3828 | 0.140 |
Why?
|
Alleles | 5 | 2021 | 6893 | 0.140 |
Why?
|
Tandem Mass Spectrometry | 3 | 2021 | 1197 | 0.130 |
Why?
|
Amino Acid Sequence | 11 | 2021 | 13411 | 0.130 |
Why?
|
Peptide Fragments | 4 | 2018 | 5141 | 0.130 |
Why?
|
HLA-A Antigens | 3 | 2010 | 223 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 371 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2024 | 1266 | 0.130 |
Why?
|
Cell Differentiation | 4 | 2017 | 11657 | 0.130 |
Why?
|
Macrophages | 4 | 2021 | 5785 | 0.120 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 940 | 0.120 |
Why?
|
Mice | 25 | 2024 | 81912 | 0.120 |
Why?
|
Lectins, C-Type | 1 | 2018 | 591 | 0.120 |
Why?
|
Ligands | 2 | 2019 | 3273 | 0.110 |
Why?
|
Algorithms | 6 | 2019 | 14098 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2019 | 2040 | 0.110 |
Why?
|
Leukemia | 1 | 2021 | 1518 | 0.110 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1319 | 0.110 |
Why?
|
Gene Expression Profiling | 6 | 2023 | 9532 | 0.110 |
Why?
|
Multiple Myeloma | 2 | 2024 | 5186 | 0.110 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1596 | 0.110 |
Why?
|
HLA-A2 Antigen | 2 | 2010 | 207 | 0.100 |
Why?
|
Blastomeres | 1 | 2012 | 29 | 0.100 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2022 | 4405 | 0.100 |
Why?
|
Immunoconjugates | 1 | 2020 | 975 | 0.100 |
Why?
|
Antigens, CD | 4 | 2018 | 4032 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1405 | 0.100 |
Why?
|
Phosphoglycerate Kinase | 1 | 2012 | 66 | 0.100 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2012 | 79 | 0.100 |
Why?
|
Animals | 30 | 2024 | 168965 | 0.100 |
Why?
|
beta Karyopherins | 1 | 2012 | 46 | 0.100 |
Why?
|
Proteomics | 2 | 2023 | 3913 | 0.100 |
Why?
|
Cyclophilin A | 1 | 2012 | 57 | 0.100 |
Why?
|
Vaccination | 4 | 2024 | 3434 | 0.100 |
Why?
|
Cell Line, Tumor | 8 | 2024 | 17097 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1882 | 0.100 |
Why?
|
Tryptophan | 3 | 2003 | 484 | 0.100 |
Why?
|
Major Histocompatibility Complex | 1 | 2015 | 879 | 0.100 |
Why?
|
Genes, MHC Class I | 1 | 2012 | 236 | 0.100 |
Why?
|
Tumor Microenvironment | 5 | 2024 | 3944 | 0.100 |
Why?
|
Biopsy | 1 | 2023 | 6777 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1502 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 8628 | 0.090 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2011 | 82 | 0.090 |
Why?
|
RNA, Messenger | 3 | 2019 | 12793 | 0.090 |
Why?
|
Adoptive Transfer | 5 | 2018 | 828 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2902 | 0.090 |
Why?
|
Keratinocytes | 2 | 2012 | 876 | 0.090 |
Why?
|
Antibodies, Monoclonal | 4 | 2018 | 9245 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2015 | 4210 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2629 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6067 | 0.080 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 2010 | 113 | 0.080 |
Why?
|
Allergy and Immunology | 1 | 2011 | 170 | 0.080 |
Why?
|
Sulfonamides | 1 | 2019 | 1982 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1885 | 0.080 |
Why?
|
Polyglycolic Acid | 1 | 2011 | 406 | 0.080 |
Why?
|
Graft vs Host Disease | 2 | 2020 | 3049 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 1 | 2017 | 1814 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2014 | 961 | 0.080 |
Why?
|
Data Mining | 1 | 2014 | 561 | 0.080 |
Why?
|
Software | 4 | 2023 | 4472 | 0.080 |
Why?
|
Chromosomes, Human, Y | 1 | 2010 | 163 | 0.080 |
Why?
|
rap1 GTP-Binding Proteins | 1 | 2008 | 51 | 0.080 |
Why?
|
Histocompatibility | 1 | 2010 | 322 | 0.080 |
Why?
|
Microarray Analysis | 2 | 2009 | 751 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2815 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2800 | 0.080 |
Why?
|
Human papillomavirus 16 | 1 | 2010 | 268 | 0.080 |
Why?
|
Virulence Factors | 1 | 2011 | 498 | 0.070 |
Why?
|
Interferon-gamma | 3 | 2012 | 3154 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2023 | 4049 | 0.070 |
Why?
|
Lod Score | 1 | 2008 | 600 | 0.070 |
Why?
|
Autoimmune Diseases | 2 | 2011 | 2255 | 0.070 |
Why?
|
Papillomaviridae | 1 | 2014 | 1139 | 0.070 |
Why?
|
Candida | 1 | 2009 | 171 | 0.070 |
Why?
|
Papillomavirus Vaccines | 1 | 2014 | 497 | 0.070 |
Why?
|
Embryonic Development | 1 | 2012 | 722 | 0.070 |
Why?
|
Knowledge Bases | 2 | 2021 | 97 | 0.070 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 686 | 0.070 |
Why?
|
DNA Methylation | 2 | 2018 | 4426 | 0.070 |
Why?
|
Viral Proteins | 2 | 2011 | 1801 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5796 | 0.070 |
Why?
|
Protein Carbonylation | 1 | 2006 | 27 | 0.070 |
Why?
|
Mice, Transgenic | 6 | 2023 | 9551 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2014 | 1758 | 0.070 |
Why?
|
Cells, Cultured | 6 | 2019 | 18989 | 0.070 |
Why?
|
Stem Cell Factor | 1 | 2007 | 194 | 0.070 |
Why?
|
Transcription Factors | 3 | 2023 | 12158 | 0.070 |
Why?
|
Autoantigens | 1 | 2010 | 890 | 0.070 |
Why?
|
Genes | 1 | 2010 | 1824 | 0.070 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2010 | 549 | 0.070 |
Why?
|
Interleukin-15 | 1 | 2007 | 186 | 0.060 |
Why?
|
Macrophages, Alveolar | 1 | 2008 | 413 | 0.060 |
Why?
|
Mitochondria | 1 | 2019 | 3678 | 0.060 |
Why?
|
Tumor Cells, Cultured | 3 | 2022 | 6106 | 0.060 |
Why?
|
Antibody Formation | 1 | 2010 | 1392 | 0.060 |
Why?
|
Latent Tuberculosis | 1 | 2009 | 223 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3186 | 0.060 |
Why?
|
Transfection | 4 | 2007 | 5753 | 0.060 |
Why?
|
Lactic Acid | 1 | 2011 | 1139 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9410 | 0.060 |
Why?
|
Superoxides | 1 | 2006 | 388 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4903 | 0.060 |
Why?
|
Transplantation, Homologous | 3 | 2021 | 4838 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1105 | 0.060 |
Why?
|
Jurkat Cells | 2 | 2018 | 740 | 0.060 |
Why?
|
Interleukin-10 | 2 | 2008 | 1182 | 0.060 |
Why?
|
Proteins | 2 | 2011 | 6001 | 0.060 |
Why?
|
Antigen-Presenting Cells | 3 | 2022 | 960 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5389 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 2212 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4282 | 0.060 |
Why?
|
Computational Biology | 3 | 2010 | 3567 | 0.060 |
Why?
|
Gene Targeting | 1 | 2007 | 841 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2020 | 5716 | 0.060 |
Why?
|
Molecular Sequence Data | 6 | 2014 | 17608 | 0.050 |
Why?
|
Cloning, Molecular | 2 | 2019 | 4167 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2008 | 2342 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2023 | 159 | 0.050 |
Why?
|
B-Cell Maturation Antigen | 1 | 2024 | 148 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2015 | 3698 | 0.050 |
Why?
|
Phagocytosis | 1 | 2008 | 1526 | 0.050 |
Why?
|
Vaccines, DNA | 1 | 2024 | 279 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11872 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2023 | 251 | 0.050 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2009 | 836 | 0.050 |
Why?
|
Oxygenases | 1 | 2002 | 59 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1168 | 0.050 |
Why?
|
Autoantibodies | 1 | 2010 | 2114 | 0.050 |
Why?
|
Amino Acids | 1 | 2008 | 1712 | 0.050 |
Why?
|
Chemical Fractionation | 1 | 2021 | 60 | 0.050 |
Why?
|
Aquaporin 4 | 1 | 2022 | 161 | 0.050 |
Why?
|
Stromal Cells | 1 | 2007 | 1335 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4780 | 0.050 |
Why?
|
Phenotype | 5 | 2022 | 16718 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2023 | 2887 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13650 | 0.050 |
Why?
|
B-Lymphocytes | 2 | 2011 | 4787 | 0.040 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22361 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4280 | 0.040 |
Why?
|
Influenza, Human | 1 | 2011 | 1543 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 2002 | 454 | 0.040 |
Why?
|
Protein Binding | 4 | 2017 | 9327 | 0.040 |
Why?
|
Graft vs Leukemia Effect | 1 | 2020 | 121 | 0.040 |
Why?
|
Oligopeptides | 1 | 2005 | 1195 | 0.040 |
Why?
|
Prostaglandins | 1 | 2001 | 398 | 0.040 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 2131 | 0.040 |
Why?
|
Desmoglein 3 | 2 | 2010 | 9 | 0.040 |
Why?
|
Female | 18 | 2024 | 396660 | 0.040 |
Why?
|
Potassium Channels | 1 | 2022 | 534 | 0.040 |
Why?
|
Ribonuclease H | 1 | 2019 | 52 | 0.040 |
Why?
|
Dioxygenases | 1 | 2002 | 353 | 0.040 |
Why?
|
CpG Islands | 1 | 2024 | 1206 | 0.040 |
Why?
|
Nanoparticles | 1 | 2011 | 1966 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2017 | 1442 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2012 | 1989 | 0.040 |
Why?
|
Antirheumatic Agents | 1 | 2008 | 1379 | 0.040 |
Why?
|
Liposomes | 2 | 2015 | 787 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13491 | 0.040 |
Why?
|
Melanoma-Specific Antigens | 1 | 2018 | 73 | 0.040 |
Why?
|
Down-Regulation | 2 | 2002 | 2931 | 0.040 |
Why?
|
Cell Adhesion | 2 | 2002 | 3093 | 0.040 |
Why?
|
Mycobacterium tuberculosis | 1 | 2009 | 1911 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2023 | 1027 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 6226 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2010 | 3582 | 0.040 |
Why?
|
Integrin alpha Chains | 1 | 2017 | 93 | 0.040 |
Why?
|
Automation | 1 | 2020 | 587 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 501 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2023 | 11923 | 0.030 |
Why?
|
Microglia | 1 | 2005 | 1370 | 0.030 |
Why?
|
Artificial Intelligence | 1 | 2011 | 2666 | 0.030 |
Why?
|
Cell Communication | 1 | 2023 | 1660 | 0.030 |
Why?
|
Haplotypes | 1 | 2022 | 2722 | 0.030 |
Why?
|
Middle Aged | 7 | 2019 | 223233 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1621 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5924 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2020 | 733 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2023 | 1608 | 0.030 |
Why?
|
HLA-DR2 Antigen | 2 | 2005 | 44 | 0.030 |
Why?
|
Young Adult | 3 | 2018 | 59980 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 2010 | 1765 | 0.030 |
Why?
|
Orthomyxoviridae Infections | 1 | 2017 | 255 | 0.030 |
Why?
|
Paclitaxel | 1 | 2022 | 1728 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 2 | 2015 | 3738 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2017 | 447 | 0.030 |
Why?
|
Optical Tweezers | 1 | 2015 | 83 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2007 | 3408 | 0.030 |
Why?
|
Models, Molecular | 2 | 2015 | 5388 | 0.030 |
Why?
|
Cell Separation | 2 | 2011 | 1717 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2008 | 3114 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2428 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2023 | 2843 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1352 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3552 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6287 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3804 | 0.030 |
Why?
|
Mutation | 2 | 2017 | 30211 | 0.030 |
Why?
|
Aged | 5 | 2019 | 171319 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3667 | 0.030 |
Why?
|
Mass Screening | 1 | 2008 | 5456 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3440 | 0.020 |
Why?
|
Male | 11 | 2021 | 364203 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3468 | 0.020 |
Why?
|
Disulfides | 1 | 2014 | 462 | 0.020 |
Why?
|
Spleen | 1 | 2018 | 2292 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2002 | 511 | 0.020 |
Why?
|
Tissue Donors | 1 | 2021 | 2387 | 0.020 |
Why?
|
Adult | 5 | 2019 | 223317 | 0.020 |
Why?
|
Coculture Techniques | 2 | 2008 | 1337 | 0.020 |
Why?
|
Desmoglein 1 | 1 | 2010 | 7 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2019 | 5332 | 0.020 |
Why?
|
Non-Fibrillar Collagens | 1 | 2010 | 24 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3608 | 0.020 |
Why?
|
Integrin alpha6 | 1 | 2010 | 30 | 0.020 |
Why?
|
Integrin beta4 | 1 | 2010 | 29 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2014 | 1160 | 0.020 |
Why?
|
Nanostructures | 1 | 2015 | 549 | 0.020 |
Why?
|
Protein Subunits | 1 | 2014 | 940 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2011 | 5891 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2015 | 2745 | 0.020 |
Why?
|
Epitope Mapping | 1 | 2011 | 301 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1655 | 0.020 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2010 | 109 | 0.020 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2012 | 430 | 0.020 |
Why?
|
HLA-DQ Antigens | 1 | 2010 | 190 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7210 | 0.020 |
Why?
|
Autophagy | 1 | 2018 | 1347 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2012 | 839 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2014 | 994 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2012 | 335 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1995 | 0.020 |
Why?
|
Cytoplasm | 1 | 2014 | 1504 | 0.020 |
Why?
|
Consumer Product Safety | 1 | 2010 | 122 | 0.020 |
Why?
|
Cell Lineage | 2 | 2012 | 2575 | 0.020 |
Why?
|
Tuberculin | 1 | 2009 | 63 | 0.020 |
Why?
|
Guanine Nucleotide-Releasing Factor 2 | 1 | 2008 | 5 | 0.020 |
Why?
|
Immunologic Capping | 1 | 2008 | 30 | 0.020 |
Why?
|
Mechanotransduction, Cellular | 1 | 2014 | 539 | 0.020 |
Why?
|
Azathioprine | 1 | 2010 | 354 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5794 | 0.020 |
Why?
|
Drug Compounding | 1 | 2010 | 236 | 0.020 |
Why?
|
Academies and Institutes | 1 | 2011 | 326 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 609 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 16036 | 0.020 |
Why?
|
Drug Contamination | 1 | 2010 | 151 | 0.020 |
Why?
|
Janus Kinase 3 | 1 | 2009 | 75 | 0.020 |
Why?
|
Oncogene Proteins, Viral | 1 | 2010 | 342 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2020 | 3076 | 0.020 |
Why?
|
U937 Cells | 1 | 2008 | 260 | 0.020 |
Why?
|
Cell Proliferation | 3 | 2009 | 10455 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2906 | 0.020 |
Why?
|
Tuberculin Test | 1 | 2009 | 205 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2012 | 2176 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2221 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2827 | 0.020 |
Why?
|
Second Messenger Systems | 1 | 2008 | 203 | 0.020 |
Why?
|
Plasma Cells | 1 | 2011 | 599 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2012 | 1524 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 874 | 0.020 |
Why?
|
Cyclosporine | 1 | 2010 | 778 | 0.020 |
Why?
|
Bystander Effect | 1 | 2008 | 89 | 0.020 |
Why?
|
Antibodies | 1 | 2015 | 2419 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2019 | 65295 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2010 | 899 | 0.020 |
Why?
|
Pregnancy | 2 | 2007 | 30238 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3760 | 0.020 |
Why?
|
Apoptosis | 2 | 2019 | 9513 | 0.020 |
Why?
|
Signal Transduction | 3 | 2023 | 23621 | 0.020 |
Why?
|
Prognosis | 1 | 2008 | 29963 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5693 | 0.020 |
Why?
|
Benzamides | 1 | 2012 | 1376 | 0.020 |
Why?
|
Bronchi | 1 | 2010 | 847 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 18063 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2010 | 792 | 0.020 |
Why?
|
Antigens, Surface | 1 | 2010 | 1617 | 0.020 |
Why?
|
Candidiasis | 1 | 2009 | 366 | 0.020 |
Why?
|
Up-Regulation | 2 | 2007 | 4143 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 696 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 694 | 0.020 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2010 | 463 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1966 | 0.020 |
Why?
|
Antigens | 1 | 2011 | 1442 | 0.020 |
Why?
|
Patient Compliance | 1 | 2015 | 2697 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14766 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2476 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1326 | 0.010 |
Why?
|
Isoantigens | 1 | 2007 | 562 | 0.010 |
Why?
|
Virulence | 1 | 2009 | 1294 | 0.010 |
Why?
|
Disease | 1 | 2010 | 675 | 0.010 |
Why?
|
Cell Membrane | 1 | 2014 | 3642 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2010 | 2227 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2008 | 1472 | 0.010 |
Why?
|
Interleukin-17 | 1 | 2010 | 922 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4572 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2011 | 14476 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 2009 | 1148 | 0.010 |
Why?
|
Receptors, Interleukin-3 | 1 | 2002 | 29 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 1368 | 0.010 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 1 | 2002 | 36 | 0.010 |
Why?
|
Receptors, CCR6 | 1 | 2002 | 73 | 0.010 |
Why?
|
Cattle | 1 | 2008 | 3813 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13646 | 0.010 |
Why?
|
Thymus Gland | 1 | 2007 | 1264 | 0.010 |
Why?
|
Enzyme Inhibitors | 2 | 2002 | 3726 | 0.010 |
Why?
|
Piperazines | 1 | 2012 | 2548 | 0.010 |
Why?
|
Receptors, Immunologic | 1 | 2008 | 1418 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6014 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 2002 | 439 | 0.010 |
Why?
|
Drug Approval | 1 | 2008 | 820 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12414 | 0.010 |
Why?
|
Risk Factors | 1 | 2008 | 74886 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 2002 | 445 | 0.010 |
Why?
|
RNA, Antisense | 1 | 2001 | 136 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1626 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2007 | 1894 | 0.010 |
Why?
|
Models, Immunological | 1 | 2003 | 516 | 0.010 |
Why?
|
Transplantation Immunology | 1 | 2002 | 537 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59548 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 319 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 1672 | 0.010 |
Why?
|
Pyrimidines | 1 | 2012 | 3044 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 897 | 0.010 |
Why?
|
Drug Design | 1 | 2005 | 1045 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7587 | 0.010 |
Why?
|
Metalloendopeptidases | 1 | 2001 | 386 | 0.010 |
Why?
|
Receptors, Chemokine | 1 | 2002 | 652 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2010 | 2979 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3797 | 0.010 |
Why?
|
Genetic Variation | 1 | 2014 | 6611 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 81659 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9360 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4401 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11063 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 13035 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2010 | 4925 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2002 | 976 | 0.010 |
Why?
|
Databases, Factual | 1 | 2011 | 8068 | 0.010 |
Why?
|
Calcium | 1 | 2008 | 5792 | 0.010 |
Why?
|
Skin | 1 | 2008 | 4499 | 0.010 |
Why?
|
MicroRNAs | 1 | 2010 | 3792 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20169 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 4473 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12986 | 0.010 |
Why?
|
Inflammation | 2 | 2003 | 10869 | 0.010 |
Why?
|
Rats | 1 | 2008 | 23713 | 0.010 |
Why?
|
United States | 1 | 2008 | 72971 | 0.000 |
Why?
|